Is metformin (biguanide) effective for weight loss in individuals without diabetes mellitus?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: June 16, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

Metformin can be effective for weight loss in individuals without diabetes mellitus, with approximately 3% weight loss and 25% to 50% of participants achieving at least 5% weight loss, as seen in a 2023 review published in JAMA 1. When considering metformin for weight loss in non-diabetic individuals, it's essential to note that the medication is not FDA-approved for this purpose. However, the available evidence suggests that metformin can produce modest weight loss, particularly when used in doses greater than 1500 mg, with twice-daily dosing potentially offering additional benefits due to its effects on hunger and ghrelin levels 1. Some key points to consider when using metformin for weight loss in individuals without diabetes include:

  • The medication's pleiotropic effects, which include decreased inflammation, increased insulin and leptin sensitivity, and decreased hunger and ghrelin levels 1
  • The potential for metformin to be most beneficial for individuals with insulin resistance, prediabetes, or polycystic ovary syndrome
  • The importance of lifestyle modifications, including diet and exercise, as the cornerstone of weight management, which should be implemented alongside any medication
  • The limited long-term safety data for metformin use specifically for weight loss in non-diabetic individuals, although the drug has a well-established safety profile in diabetic populations 1

From the Research

Effectiveness of Metformin for Weight Loss in Non-Diabetic Individuals

  • Metformin is typically used to treat type 2 diabetes, but its effectiveness for weight loss in non-diabetic individuals is also being studied 2, 3, 4.
  • A study published in 2019 found that metformin increased endogenous glucose production in non-diabetic individuals, but did not affect body weight or composition 2.
  • Another study from 1996 found that metformin improved blood lipid patterns in non-diabetic patients with coronary heart disease and also reduced body weight in overweight patients 3.
  • A 2001 study on obese adolescents with fasting hyperinsulinemia and a family history of type 2 diabetes found that metformin caused a decline in BMI and a reduction in fasting insulin levels, suggesting its potential for weight loss in this population 4.

Metformin's Mechanism of Action and Potential Benefits

  • Metformin's mechanism of action is not fully understood, but it is thought to increase glucose uptake in tissues and decrease glucose production in the liver 2, 5.
  • Metformin has been shown to have potential benefits beyond glucose control, including improving blood lipid patterns, reducing weight, and decreasing the risk of cardiovascular disease 3, 5, 6.
  • The use of metformin for weight loss in non-diabetic individuals may be considered, especially for those with a high risk of developing type 2 diabetes or cardiovascular disease 6.

Limitations and Potential Side Effects

  • More research is needed to fully understand the effects of metformin on weight loss in non-diabetic individuals and to determine its potential side effects and limitations 2, 3, 4.
  • Common side effects of metformin include gastrointestinal symptoms such as diarrhea and abdominal discomfort, but these are typically transient and well-tolerated 4.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.